CORC  > 复旦大学上海医学院
RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis.
Cosgriff, Thomas; Yang, Lin; Alyasova, Anna; Ye, Dingwei; Karpenko, Andrey; Li, Hanzhong; Alekseev, Boris; Xie, Li-ping; Kowalyszyn, Ruben Dario; Karyakin, Oleg
2016
卷号34
期号2
会议录JOURNAL OF CLINICAL ONCOLOGY
语种英语
URL标识查看原文
ISSN号0732-183X
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/3625801
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Cosgriff, Thomas,Yang, Lin,Alyasova, Anna,et al. RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis.[C]. 见:.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace